Among patients with CAD, PTSD is associated with both incident and recurrent heart failure hospitalizations. Post-traumatic stress disorder (PTSD) is linked with incident and recurrent heart failure ...
A biopharmaceutical company dedicated to psychedelic treatment announced last week that its clinical trial on MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”) produced encouraging ...
These data represent one of the largest clinical development programs to date for adults living with PTSD and a significant development in a therapy area that hasn’t seen a new approval for a ...
Credit: Getty Images. Significant factors limit MDMA’s ability to be used in the treatment of post-traumatic stress disorder. Significant factors limit MDMA’s ability to be used in the treatment of ...
For veterans battling post-traumatic stress disorder, feeling better is more than just scoring better in clinical measurements. A new study shows that these two metrics often align.
Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...
The results will be used to seek FDA approval of MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder. Treating post-traumatic stress disorder (PTSD) with a combination of ...
As ever-increasing numbers of soldiers are being diagnosed with post-traumatic stress disorder (PTSD), the need to understand this complex and troubling experience grows larger. In order to better ...
Compass Pathways has navigated to another successful midphase readout, linking its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder (PTSD) in a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback